Search research articles
Contact Us
Filters
Showing results (51-60 of 77) with videos related to
Page
of 8
Sort By:
Current Medical Research and Opinion
|
April 12, 2021
Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey
G Walter Canonica, Ludger Klimek, Sarah Acaster, et al.
Current Allergy and Asthma Reports
|
December 5, 2024
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Peter W Hellings, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2010
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Stephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
Nature Reviews. Disease Primers
|
December 4, 2020
Allergic rhinitis
Jean Bousquet, Josep M Anto, Claus Bachert, et al.
Current Medical Research and Opinion
|
April 7, 2025
Letter to the editor: author response for "why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review"
Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
International Forum of Allergy & Rhinology
|
July 14, 2021
A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitis
Pauline Van Bulck, Leen Cools, Mysore S Soumya, et al.
Journal of Asthma and Allergy
|
December 9, 2020
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
Ranny van Weissenbruch, Ludger Klimek, Gabriella Gálffy, et al.
Current Medical Research and Opinion
|
July 19, 2024
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review
Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
The Journal of Allergy and Clinical Immunology
|
January 31, 2012
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
Stephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
The World Allergy Organization Journal
|
May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
Glenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Page
of 8
Search research articles
Search
Showing results (51-60 of 77) with videos related to
Sort By:
Page
of 8
Current Medical Research and Opinion
|
April 12, 2021
Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey
G Walter Canonica, Ludger Klimek, Sarah Acaster, et al.
Current Allergy and Asthma Reports
|
December 5, 2024
Thymic Stromal Lymphopoietin (TSLP): Evidence in Respiratory Epithelial-driven Diseases Including Chronic Rhinosinusitis with Nasal Polyps
Eugenio De Corso, Peter W Hellings, Wytske J Fokkens, et al.
The Journal of Allergy and Clinical Immunology
|
January 30, 2010
Long-term clinical efficacy in grass pollen-induced rhinoconjunctivitis after treatment with SQ-standardized grass allergy immunotherapy tablet
Stephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
Nature Reviews. Disease Primers
|
December 4, 2020
Allergic rhinitis
Jean Bousquet, Josep M Anto, Claus Bachert, et al.
Current Medical Research and Opinion
|
April 7, 2025
Letter to the editor: author response for "why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review"
Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
International Forum of Allergy & Rhinology
|
July 14, 2021
A multicenter real-life study on the multiple reasons for uncontrolled allergic rhinitis
Pauline Van Bulck, Leen Cools, Mysore S Soumya, et al.
Journal of Asthma and Allergy
|
December 9, 2020
MP-AzeFlu Improves the Quality-of-Life of Patients with Allergic Rhinitis
Ranny van Weissenbruch, Ludger Klimek, Gabriella Gálffy, et al.
Current Medical Research and Opinion
|
July 19, 2024
Why fexofenadine is considered as a truly non-sedating antihistamine with no brain penetration: a systematic review
Ignacio J Ansotegui, Jean Bousquet, Giorgio Walter Canonica, et al.
The Journal of Allergy and Clinical Immunology
|
January 31, 2012
SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial
Stephen R Durham, Waltraud Emminger, Alexander Kapp, et al.
The World Allergy Organization Journal
|
May 20, 2020
Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement
Glenis K Scadding, Peter W Hellings, Claus Bachert, et al.
Page
of 8